Delivery Order SPE2DB22D3010-SPE2DB25FP2AN
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ20U, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,784.96, is a delivery order for the supply of 4566529414 - VYVANSE 10 MG CAPSULE 100S. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, with an ID of SPE2DB24D1034|SPE2DB25FVZW6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $1,783.60 and a period of performance through January 17, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award, with ID SPE2DB20D1051|SPE2DB25FD5YH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566188939 VYVANSE 30 MG CAPSULE 100S, with a ceiling value of $2,196.04. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 24, 2024. The contract was awarded on October 23, 2024 and does not have a set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,346.26 and a completion date of May 15, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $1,720.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567553029 ! VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. This contract is a delivery order and has a firm fixed price pricing type. The contract has an ultimate completion date of March 12, 2025 and was awarded on March 11, 2025. The contract does not...
This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFKQL, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4567781919 ! VYVANSE 50 MG CAPSULE 100S. The contract has a ceiling value of $1,859.01 and is a Firm Fixed Price Delivery Order. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, with no major subcontractors mentioned. This contract is part of a larger...
This federal contract award, with the ID SPE2DB20D1110|SPE2DB25FJ97F, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,925.11, is for the delivery of 4567376036 VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date for this award is February 26, 2025. This contract award is not designated as a Set-Aside and...
This federal contract award, with an ID of SPE2DB24D2205|SPE2DB25FEBDC, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,567,957,290 units of the pharmaceutical product VYVANSE 20 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order, with a ceiling value of $3,401.60 and an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, identified as SPE2DB20D3505|SPE2DB25FU1Y8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567604164 VYVANSE 60 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,337.70 and a performance period through March 18, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYVANSE 20 MG CAPSULE 100S. The contract has a ceiling value of $1,600.66 and a period of performance through April 29, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...